Fasciola hepatica: Influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole

Experimental Parasitology

Volumn 94, Issue 4, 2000, Pages 227-237

  Sibille, Pierre ^a   Calléja, Cécile ^a   Carreras, Florence ^a   Bigot, Karine ^a   Galtier, Pierre ^a   Boulard, Chantal ^a  

^a CEMAGREF   (France)

Author keywords

Fasciola hepatica; GST; Ivomec(R) D; P450; Rat; Sex; Triclabendazole

Indexed keywords

CLORSULON; CYTOCHROME P450; IVERMECTIN; IVOMEC D; LIVER ENZYME; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; DRUG SENSITIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; GENDER; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 17944384849     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.2000.4501     Document Type: Article

References (35)

1. Apt W., Aguilera X., Vega F., Miranda C., Zulantay I., Perez C., Gabor M., Apt P. Treatment of human chronic fascioliasis with triclabendazole: Drug efficacy and serologic response. American Journal for Tropical and Medicinal Hygiene. 52:1995;532-535.
2. Baeza E., Poitou I., Boulard C. Influence of pro-inflammatory treatments on experimental infection of rats with Fasciola hepatica: Changes in serum levels of inflammatory markers during the early stages of fasciolosis. Research in Veterinary Sciences. 57:1994a;180-187.
3. Baeza E., Poitou I., Delers F., Boulard C. Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: Changes in serum levels of inflammatory markers during the early stages of fasciolosis. Research in Veterinary Sciences. 57:1994b;172-179.
4. Biro Sauveur B., Eeckhoutte C., Baeza E., Boulard C., Galtier P. Comparison of hepatic and extrahepatic drug-metabolizing enzyme activities in rats given single or multiple challenge infections with Fasciola hepatica. International Journal for Parasitology. 25:1995;1193-1200.
5. Boray J. C., Crowfoot P. D., Strong M. B., Allison J. R., Schellenbaum M., Von Orelli M., Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Records. 113:1983;315-317.
6. Chengelis C. P. Age- and sex-related changes in the components of the hepatic microsomal mixed function oxidase system in Sprague-Dawley rats. Xenobiotica. 18:1988;1211-1224.
7. Cochin J, Axelrod J. Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine or normorphine. Journal for Pharmacological and Experimental Therapeutics. 125:1959;105-115.
8. Corba J., Varady M., Parslicka J., Tomasovicova O. Efficacy of Ivomec R-F against naturally acquired gastrointestinal worms, lung worms (Dictyocolus filaria) and liver flukes (Fasciola hepatica) in sheep. Helminthologia. 33:1996;133-135.
9. Dorsman W., Bijl A. C. Cultivation of free-living stages of Trichostrongylus colubriformis in media without bacteria, animal tissue extract, or serum. Journal for Parasitology. 71:1985;200-203.
10. Galtier P., Alvinerie M. Pharmacological basis for hepatic drug metabolism in sheep. Veterinary Research. 27:1996;363-372.
11. Galtier P., Battaglia A., More J., Franc M. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat. Journal of Pharmacy and Pharmacology. 35:1983;729-733.
12. Galtier P., Vandenberghe Y., Coecke S., Eeckhoutte C., Larrieu G., Vercruysse A. Differential inhibition of rat hepatic glutathione S-transferase isoenzymes in the course of fascioliasis. Molecular and Biochemical Parasitology. 44:1991;255-260.
13. Guegenrich F. P. Bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metabolism and Disposition. 21:1993;1-6.
14. Habig W. H., Pabst M. J., Jakoby W. B. Gluthatione transferase, the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry. 249:1974;7130-7139.
15. Igarashi T., Satoh T., Ueno K., Kitagawa H. Sex-related difference in the hepatic glutathione level and related enzyme activities in rat. Journal of Biochemistry. 93:1983;33-36.
16. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurements with the folin phenol reagent. Journal of Biological Chemistry. 193:1951.
17. Malone J. B., Ramsey R. T., Loyacano A. F. Efficacy of clorsulon for treatment of mature naturally acquired and 8-week-old experimentally induced Fasciola hepatica infections in cattle. American Journal for Veterinary Research. 45:1984;851-854.
18. Martinez-Moreno A., Jimenez V., Martinez-Cruz M. S., Martinez-Moreno F. J., Becerra C., Hernandez S. Triclabendazole treatment in experimental goat fasciolosis: Anthelmintic efficacy and influence in antibody response and pathophysiology of the disease. Veterinary Parasitology. 68:1997;57-67.
19. Masih D. T., Cervi L., Casado J. M. Modification of accessory activity of peritoneal cells from Fasciola hepatica infected rats. Veterinary Immunology and Immunopathology. 53:1996;257-268.
20. Meinert C. L. The inclusion of women in clinical trials. Science. 269:1995;795-796.
21. Olsen O. Liver flukes in cattle: Diagnosis for treatment and prevention. Proceedings U.S.L.S.A. 52:1948;79-80.
22. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry. 239:1964;2379-2385.
23. Poitou I., Baeza E., Boulard C. Humoral and cellular immune responses in rats during a primary infestation with Fasciola hepatica. Veterinary Parasitology. 45:1992;59-71.
24. Rapic D., Dzakula N., Sakar D., Richards R. J. Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle. Veterinary Records. 122:1988;59-62.
25. Richards R. J., Bowen F. L., Essenwein F., Steiger R. F., Buscher G. The efficacy of triclabendazole and other anthelmintics against Fasciola hepatica in controlled studies in cattle. Veterinary Records. 126:1990;213-216.
26. Roseby F. B. The effect of fasciolosis on the wool production of merino sheep. Australian Veterinary Journal. 46:1970;361-365.
27. Schulman M. D., Valentino D. Fasciola hepatica: Effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro. Experimental Parasitology. 49:1980;206-215.
28. Sherman L. A., Temple R., Merkatz R. B. Women in clinical trials: An FDA perspective. Science. 269:1995;793-795.
29. Shoop W. L., Ostlind D. A., Rohrer S. P., Mickle G., Haines H. W., Michael B. F., Mrozik H., Fisher M. H. Avermectins and milbemycins against Fasciola hepatica: In vivo drug efficacy and in vitro receptor binding. International Journal for Parasitology. 25:1995;923-927.
30. Sykes A. R., Coop R. L., Rushton B. Chronic subclinical fascioliasis in sheep: Effects on food intake, food utilisation and blood constituents. Research in Veterinary Sciences. 28:1980;63-70.
31. Valero M. A., Marcos M. D., Fons R., Mascoma S. Fasciola hepatica development in the experimentally infected black rat Rattus rattus. Parasitology Research. 84:1998;188-194.
32. Wallace D. H., Kilgore R. L., Benz G. W. Clorsulon, a new fasciolicide for cattle. Modern Veterinary Practice. 66:1985;879-882.
33. Yoshimura H. Teratogenic evaluation of triclabendazole in rats. Toxicology. 43:1987;283-287.
34. Zeng Z., Andrew N. W., Woda J. M., Halley B. A., Crouch L. S., Wang R. W. Role of cytochrome P450 isoforms in the metabolism of abamectin and ivermectin in rats. Journal of Agricultural and Food Chemistry. 44:1996.
35. Zuk M., McKean K. A. Sex differences in parasite infections: Patterns and processes. International Journal for Parasitology. 26:1996;1009-1023.